SetPoint Medical, a clinical-stage healthcare company dedicated to people living with chronic autoimmune diseases, today ...

The first poster demonstrates proof-of-concept data that Aqtual's therapy selection test can predict treatment response in patients with RA. The second poster provides an interim analysis from ...

Rheumatoid arthritis (RA) patients who achieved sustained remission had better long-term outcomes than those with lingering ...

Substantial improvements in ultrasound technology and expanded use of it have necessitated an update of the 2012 ...

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today ...

The test will measure levels of the 14-3-3eta protein, which is used in the diagnosis and management of inflammatory diseases including rheumatoid arthritis.

Use of an implantable vagus nerve stimulation device was safe and effective for treating RA among patients who previously failed treatment with at least 1 b/tsDMARD.

Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...

Researchers found that while some patients showed gut instability, others with stable microbiomes did not progress to ...

Explore how the platelet-to-albumin ratio correlates with disease activity in early rheumatoid arthritis, potentially serving ...